Safe Staphylococcal Platform for the Development of Multivalent Nanoscale Vesicles against Viral Infections
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Many viruses often have closely related yet antigenically distinct serotypes. An ideal vaccine against viral infections should induce a multivalent and protective immune response against all serotypes. Inspired by bacterial membrane vesicles (MVs) that carry different protein components, we constructed an agr locus deletion mutant of the Staphylococcus aureus strain (RN4220-Δagr) to reduce potential toxicity. Nanoscale vesicles derived from this strain ( Δagr MVs) carry at least four major components that can deliver heterologous antigens. These components were each fused with a triple FLAG tag, and the tagged proteins could be incorporated into the Δagr MVs. The presentation levels were (3.43 ± 0.73)%, (5.07 ± 0.82)%, (2.64 ± 0.61)%, and (2.89 ± 0.74)% of the total Δagr MV proteins for Mntc-FLAG, PdhB-FLAG, PdhA-FLAG, and Eno-FLAG, respectively. With two DENV envelope E domain III proteins (EDIIIconA and EDIIIconB) as models, the DENV EDIIIconA and EDIIIconB delivered by two staphylococcal components were stably embedded in the Δagr MVs. Administration of such engineered Δagr MVs in mice induced antibodies against all four DENV serotypes. Sera from immunized mice protected Vero cells and suckling mice from a lethal challenge of DENV-2. This study will open up new insights into the preparation of multivalent nanosized viral vaccines against viral infections.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bacterial Infections and Vaccines · Viral Infections and Immunology Research · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Microbiology, College of Basic Medical Sciences, Third Military Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, People’s Republic of China
Department of Emergency, Xinqiao Hospital, Third Military Medical University, 83 Xinqiao Street, Shapingba District, Chongqing 400037, People’s Republic of China
Funding
Ministry of Health of the People's Republic of China · Third Military Medical University · National Natural Science Foundation of China
References (35)
Show source-provided references
1. 10.1371/journal.ppat.100482510.1371/journal.ppat.1004825 ↗
2. 10.1016/j.antiviral.2016.06.00610.1016/j.antiviral.2016.06.006 ↗
3. 10.1038/ncomms753710.1038/ncomms7537 ↗
4. 10.1038/ncomms1433910.1038/ncomms14339 ↗
5. 10.1016/B978-0-12-800098-4.00007-610.1016/B978-0-12-800098-4.00007-6 ↗
6. 10.1042/bj096056710.1042/bj0960567 ↗
7. 10.1016/j.provac.2014.07.00710.1016/j.provac.2014.07.007 ↗
8. 10.1111/j.1574-695X.2012.01004.x10.1111/j.1574-695X.2012.01004.x ↗
9. 10.1128/IAI.00950-1010.1128/IAI.00950-10 ↗
10. 10.1517/14712598.2011.58596510.1517/14712598.2011.585965 ↗
11. 10.1016/j.vaccine.2011.08.10210.1016/j.vaccine.2011.08.102 ↗
12. 10.3402/jev.v2i0.2018110.3402/jev.v2i0.20181 ↗
13. 10.1016/j.bbamcr.2013.12.01110.1016/j.bbamcr.2013.12.011 ↗
14. 10.1002/pmic.20090033810.1002/pmic.200900338 ↗
15. 10.1111/mmi.1265010.1111/mmi.12650 ↗
16. Beveridge T. J. · J. Bacteriol. · 1999 · 181 · 472510.1128/JB.181.16.4725-4733.1999 ↗
17. 10.1016/j.semcdb.2015.02.00610.1016/j.semcdb.2015.02.006 ↗
18. 10.1128/mBio.01921-1410.1128/mBio.01921-14 ↗
19. 10.1155/2017/793198210.1155/2017/7931982 ↗
20. 10.15698/mic2016.06.50810.15698/mic2016.06.508 ↗
21. 10.1016/j.mex.2014.08.00110.1016/j.mex.2014.08.001 ↗
22. 10.1111/j.1365-2958.2006.04986.x10.1111/j.1365-2958.2006.04986.x ↗
23. 10.1128/JB.00418-0610.1128/JB.00418-06 ↗
24. 10.1371/journal.pone.002795810.1371/journal.pone.0027958 ↗
25. 10.1371/journal.pone.005466110.1371/journal.pone.0054661 ↗
26. 10.1073/pnas.100884310710.1073/pnas.1008843107 ↗
27. 10.1016/j.chembiol.2016.01.00410.1016/j.chembiol.2016.01.004 ↗
28. 10.1016/j.micpath.2016.02.01410.1016/j.micpath.2016.02.014 ↗
29. 10.1016/j.vaccine.2010.08.04810.1016/j.vaccine.2010.08.048 ↗
30. 10.1038/nature1206010.1038/nature12060 ↗
31. 10.1128/JVI.75.16.7769-7773.200110.1128/JVI.75.16.7769-7773.2001 ↗
32. 10.1371/journal.ppat.100082110.1371/journal.ppat.1000821 ↗
33. 10.1016/j.vaccine.2012.07.04210.1016/j.vaccine.2012.07.042 ↗
34. 10.1016/j.jmb.2009.11.07010.1016/j.jmb.2009.11.070 ↗
35. 10.1038/nsmb.138210.1038/nsmb.1382 ↗